Israeli home device for stroke rehab receives FDA approval

Apr. 18 - Israeli company Curatronic Ltd. has announced that it has obtained US Food and Drug Administration (FDA) marketing approval for the Biomove 3000 Stroke Rehabilitation system. The Biomove 3000 system was specifically developed for home therapy following a stroke. The highly affordable battery-powered device detects extremely small electrical EMG signals that persist in paralyzed muscles after a stroke and uses these tiny signals to initiate an electrical stimulation impulse to the muscles, resulting in actual muscle movement by the patient. Curatronic Ltd. was founded in 2000 as a privately held R&D company dedicated to developing affordable, easy to use state-of-the-art stroke rehabilitation and therapy devices for use by patients at home and by professional therapists."

Source: Israel21c.org news for April 17-23, 2005 [FullText]